Literature DB >> 17986264

On the killing of mycobacteria by macrophages.

Luisa Jordao1, Christopher K E Bleck, Luis Mayorga, Gareth Griffiths, Elsa Anes.   

Abstract

Both pathogenic and non-pathogenic mycobacteria are internalized into macrophage phagosomes. Whereas the non-pathogenic types are invariably killed by all macrophages, the pathogens generally survive and grow. Here, we addressed the survival, production of nitrogen intermediates (RNI) and intracellular trafficking of the non-pathogenic Mycobacterium smegmatis, the pathogen-like, BCG and the pathogenic M. bovis in different mouse, human and bovine macrophages. The bacteriocidal effects of RNI were restricted for all bacterial species to the early stages of infection. EM analysis showed clearly that all the mycobacteria remained within phagosomes even at late times of infection. The fraction of BCG and M. bovis found in mature phagolysosomes rarely exceeded 10% of total, irrespective of whether bacteria were growing, latent or being killed, with little correlation between the extent of phagosome maturation and the degree of killing. Theoretical modelling of our data identified two different potential sets of explanations that are consistent with our results. The model we favour is one in which a small but significant fraction of BCG is killed in an early phagosome, then maturation of a small fraction of phagosomes with both live and killed bacteria, followed by extremely rapid killing and digestion of the bacteria in phago-lysosomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986264     DOI: 10.1111/j.1462-5822.2007.01067.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  46 in total

Review 1.  Killing Mycobacterium tuberculosis In Vitro: What Model Systems Can Teach Us.

Authors:  Tracy L Keiser; Georgiana E Purdy
Journal:  Microbiol Spectr       Date:  2017-06

2.  Importance of phagosomal functionality for growth restriction of Mycobacterium tuberculosis in primary human macrophages.

Authors:  Amanda Welin; Johanna Raffetseder; Daniel Eklund; Olle Stendahl; Maria Lerm
Journal:  J Innate Immun       Date:  2011-05-11       Impact factor: 7.349

3.  The Mycobacterium tuberculosis SecA2 system subverts phagosome maturation to promote growth in macrophages.

Authors:  Jonathan Tabb Sullivan; Ellen F Young; Jessica R McCann; Miriam Braunstein
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

4.  A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis.

Authors:  Kaitlyn Schaaf; Virginia Hayley; Alexander Speer; Frank Wolschendorf; Michael Niederweis; Olaf Kutsch; Jim Sun
Journal:  Assay Drug Dev Technol       Date:  2016-06-21       Impact factor: 1.738

5.  Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.

Authors:  David Pires; Emília Valente; Marta Filipa Simões; Nuno Carmo; Bernard Testa; Luís Constantino; Elsa Anes
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

6.  Agents and networks to model the dynamic interactions of intracellular transport.

Authors:  Luis S Mayorga; Meghna Verma; Raquel Hontecillas; Stefan Hoops; Josep Bassaganya-Riera
Journal:  Cell Logist       Date:  2017-11-29

7.  The Mycobacterium tuberculosis outer membrane channel protein CpnT confers susceptibility to toxic molecules.

Authors:  Olga Danilchanka; David Pires; Elsa Anes; Michael Niederweis
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

8.  Exosomal Hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria.

Authors:  Paras K Anand; Ellis Anand; Christopher K E Bleck; Elsa Anes; Gareth Griffiths
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

9.  Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages.

Authors:  Hridayesh Prakash; Anja Lüth; Natalia Grinkina; Daniela Holzer; Raj Wadgaonkar; Alexis Perez Gonzalez; Elsa Anes; Burkhard Kleuser
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

10.  Interactions of attenuated Mycobacterium tuberculosis phoP mutant with human macrophages.

Authors:  Nadia L Ferrer; Ana B Gomez; Olivier Neyrolles; Brigitte Gicquel; Carlos Martin
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.